[Federal Register Volume 67, Number 247 (Tuesday, December 24, 2002)]
[Notices]
[Page 78483]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-32360]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary and Alternative Medicine; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussion could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: National Advisory Council for Complementary and 
Alternative Medicine.
    Date: January 27, 2003.
    Closed: 8:30 to 11:30 a.m.
    Agenda: To review and evaluate grant applications and/or proposals.
    Open: 12:30 to 5:30 p.m.
    Agenda: The agenda includes opening remarks by Director, NCCAM, 
concept reviews: Dietary Supplements Resource Center; Health Services 
Research; Probiotics, and Clinical Research. Presentations: Cancer CAM 
Working Group; General Principals for Collaboration with NCI; Patient 
Focus Groups on Cancer and CAM and other business of the Council.
    Place: Neuroscience Conference Center, 6001 Executive Boulevard, 
Conference Rooms C and D, Rockville, MD 20852.
    Contact Person: Jane F. Kinsel, Ph.D., Executive Secretary, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 
20892, (301) 496-6701.
    The public comments session is scheduled from 5-5:30 p.m. Each 
speaker will be permitted 5 minutes for their presentation. Interested 
individuals and representatives of organizations are requested to 
notify Dr. Jane Kinsel, National Center for Complementary and 
Alternative Medicine, NIH, 6707 Democracy Boulevard, Suite 401, 
Bethesda, Maryland, 20892, 301-496-6701, Fax: 301-480-0087 or via email 
[email protected]. Letters of intent to present comments, along with 
a brief description of the organization represented, should be received 
no later than 5 p.m. on January 17, 2003. Only one representative of an 
organization may present oral comments. Any person attending the 
meeting who does not request an opportunity to speak in advance of the 
meeting may be considered for oral presentation, if time permits, and 
at the discretion of the Chairperson. In addition, written comments may 
be submitted to Dr. Jane Kinsel at the address listed above up to 10 
calendar days (February 6, 2003) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by Dr. Jane Kinsel, Executive Secretary, NACCAM, 
National Institutes of Health, 6707 Democracy Boulevard, Suite 401, 
Bethesda, Maryland 20892, 301--496-6701, Fax 301-480-0087, or via email 
at [email protected]. This information will be posted two weeks 
prior to the meeting on the NCCAM website at [email protected].

    Dated: December 17, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 02-32360 Filed 12-23-02; 8:45 am]
BILLING CODE 4140-01-M